Top Abstract Purchase Related
Home
>
Node
>
Subnode

Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy

Bereznaya, N.M.; Chekhun, V.F.

Experimental Oncology 29(1): 2-12

2007

ISSN/ISBN: 1812-9269
PMID: 17431376
Document Number: 613142
In the review the modern insights on the role of expression of CD40 and CD40L and the role of their interaction on tumor cells growth are analyzed. Information about the structure and biologic properties of these molecules and their interaction is presented. The question on the role of CD40/CD40L interaction is highlighted in two aspects--the possibility of tumor growth inhibition and its stimulation. According to the mentioned aspects, immunologic mechanisms providing tumor growth inhibition (the role of dendritic cells, macrophages, monocytes, cytotoxic T-lymphocytes, natural killer cells etc.), and also the possibility of apoptotic events are discussed. Possibility of tumor growth stimulation upon the influence of CD40/CD40L interaction that could occur in some cases is analyzed as well. The data of literature about new approaches to immunotherapy of cancer based on CD40/CD40L interactionare summarized.

Document emailed within 1 workday
Secure & encrypted payments

Altomonte, M.; Gloghini, A.; Bertola, G.; Gasparollo, A.; Carbone, A.; Ferrone, S.; Maio, M. 1993: Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells Cancer Research 53(14): 3343-3348
Levine, A.S.; Patch, C.T.; Hauser, J.; Cook, J.L.; Lewis, A.M. 1984: Novel role of viral gene expression in determining the tumor-inducing capacity of transformed cells Transplantation Proceedings 16(2): 441-448
Dorosevich, A.E.; Dubenskaia, L.I.; Baryshnikov, A.I.; Abrosimov, S.I. 1994: Expression of a series of leukocyte and non-leukocyte antigens in breast cancer tissues after local irradiation as a morphologic manifestation of the interaction of parenchymal cells and tumor stroma Arkhiv Patologii 56(3): 51-55
Zieglschmid, V.; Hollmann, C.; Mannel, J.; Albert, W.; Jaeschke-Melli, S.; Eckstein, B.; Hillemann, T.; Greten, T.F.; Gross, E.; Böcher, O. 2007: Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer Anticancer Research 27(4a): 1823-1832
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399
Shinomiya, Y.; Harada, M.; Tamada, K.; Kurosawa, S.; Okamoto, T.; Terao, H.; Takenoyama, M.; Ito, O.; Hirashima, C.; Li, T.; Shirakusa, T.; Nomoto, K. 1997: The augmenting effect of OK432-stimulated B cells on the in vitro generation of anti-tumor cytotoxic T lymphocytes from tumor-draining lymph node cells: the possible role of interleukin-12 In Vivo 11(1): 1-8
Hamada, J.; Nagayasu, H.; Okada, F.; Li, X.; Ren, J.; Hosokawa, M.; Takeichi, N. 1993: Enhanced malignancy of tumor cells by the interaction with host cells reactive to foreign body Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(3): 417-423
Markowicz, S.; Niedzielska, J.; Kruszewski, M.; Ołdak, T.; Gajkowska, A.; Machaj, E.K.; Skurzak, H.; Pojda, Z. 2006: Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy Acta Biochimica Polonica 53(1): 203-212
Kuznetsov, V.A.; Makalkin, I.A. 1992: Bifurcation analysis of a mathematical model of the interaction of cytotoxic lymphocytes with tumor cells. the effect of immunologic amplification of tumor growth and its interconnection with other "anomolous" phenomena of oncoimmunology Biofizika 37(6): 1063-1070
Hahn, E.; Lehmann, F.G.; Ferlemann, J.; Ax, W.; Hamelmann, H.; Hort, W.; Havemann, K. 1977: Immunotherapy of a metastasized primary liver cell carcinoma with autologous tumor cells and BGC Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 1205-1208
Koldovsky, P.; Weinstein, J. 1973: Expression of non-tumor-specific antigen in human tumor cells National Cancer Institute Monograph 37: 33-35
Kuznetsov, V.A.; Zhivoglyadov, V.P.; Stepanova, L.A. 1993: Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor Archivum Immunologiae et Therapiae Experimentalis 41(1): 21-31
Simmons, R.L.; Rios, A. 1973: Neuraminidase treated cells and their role in cancer immunotherapy Birth Defects Original Article Series 9(2): 223-228
Thurnher, M.; Papesh, C.; Ramoner, R.; Gastl, G.; Böck, G.; Radmayr, C.; Klocker, H.; Bartsch, G. 1997: In vitro generation of CD83+ human blood dendritic cells for active tumor immunotherapy Experimental Hematology 25(3): 232-237
Nishimura, T.; Kuge, S.; Watanabe, K.; Lee, U.; Yahata, T.; Habu, S. 1994: An efficient methods for the induction of human antitumor effector CD4+ and CD8+ T cells: their application to tumor immunotherapy Human Cell 7(3): 131-137
Steiner, M. 1982: Interaction of platelets and tumor cells Progress in Clinical and Biological Research 89: 383-403
Cowdery, J.S.; Pitts, A.K. 1988: Role of T cells in regulating expression of the B cell repertoire. Anti-ssDNA precursor frequency of DBA/2 B cells is increased in the presence of T cells from NZB mice Journal of Immunology 140(5): 1380-1384
Nakano, K.; Masuda, T. 1983: Involvement of carbohydrate moieties in the expression of effector activity of cytotoxic T cells against syngeneic tumor cells Gan 74(4): 568-575
Tomova, A.S.; Romanova, I.M.; Gintsburg, A.L. 2005: The role of tumor necrosis factor-alfa in the interaction between the macro- and microorganism Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2005(1): 24-29
Pai, S.R.; Bird, R.C. 1997: Interaction of the Rb tumor suppressor protein with the c-fos promoter in c-fos transfected cells overexpressing c-fos and Rb Anticancer Research 17(5a): 3265-3272